BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27114276)

  • 1. Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.
    Arnold MS; Engel JA; Chua MJ; Fisher GM; Skinner-Adams TS; Andrews KT
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4361-3. PubMed ID: 27114276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.
    van Schalkwyk DA; Moon RW; Blasco B; Sutherland CJ
    J Antimicrob Chemother; 2017 Nov; 72(11):3051-3058. PubMed ID: 28961865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
    Fidock DA; Nomura T; Wellems TE
    Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Endochin-Like Quinolones Exhibit Potent
    van Schalkwyk DA; Riscoe MK; Pou S; Winter RW; Nilsen A; Duffey M; Moon RW; Sutherland CJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of human Plasmodium knowlesi infections to anti-malarials.
    Fatih FA; Staines HM; Siner A; Ahmed MA; Woon LC; Pasini EM; Kocken CH; Singh B; Cox-Singh J; Krishna S
    Malar J; 2013 Nov; 12():425. PubMed ID: 24245918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
    Childs GE; Lambros C
    Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of simian malarial parasite (Plasmodium knowlesi)-induced putrescine transport in rhesus monkey erythrocytes. A novel putrescine conjugate arrests in vitro growth of simian malarial parasite (Plasmodium knowlesi) and cures multidrug resistant murine malaria (Plasmodium yoelii) infection in vivo.
    Singh S; Puri SK; Singh SK; Srivastava R; Gupta RC; Pandey VC
    J Biol Chem; 1997 May; 272(21):13506-11. PubMed ID: 9153195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum.
    van Schalkwyk DA; Blasco B; Davina Nuñez R; Liew JWK; Amir A; Lau YL; Leroy D; Moon RW; Sutherland CJ
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():93-99. PubMed ID: 30831468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.
    Basco LK
    Am J Trop Med Hyg; 2004 May; 70(5):474-80. PubMed ID: 15155978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
    Ndounga M; Basco LK; Ringwald P
    Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
    Watkins WM; Sixsmith DG; Chulay JD
    Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates.
    Schapira A
    Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar.
    Randrianarivelojosia M; Randrianasolo L; Randremanana RV; Randriamanantena A; Ratsimbasoa A; Rakotoson JD
    S Afr Med J; 2004 Jan; 94(1):47-51. PubMed ID: 14971233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of artemisinin (qinghaosu) and chloroquine on drug-sensitive and drug-resistant strains of Plasmodium falciparum malaria: use of [2,8-3H]adenosine as an alternative to [G-3H]hypoxanthine in the assessment of in vitro antimalarial activity.
    Ye ZG; Van Dyke K; Wimmer M
    Exp Parasitol; 1987 Dec; 64(3):418-23. PubMed ID: 3315734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
    Edstein MD; Bahr S; Kotecka B; Shanks GD; Rieckmann KH
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2300-1. PubMed ID: 9333069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of parasite clearance in Plasmodium knowlesi infections.
    T Thurai Rathnam J; Grigg MJ; Dini S; William T; Sakam SS; Cooper DJ; Rajahram GS; Barber BE; Anstey NM; Haghiri A; Rajasekhar M; Simpson JA
    Malar J; 2023 Feb; 22(1):54. PubMed ID: 36782162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of in vitro maturation of intra-erythrocytic malaria parasite: a comparison between Plasmodium falciparum and Plasmodium knowlesi.
    Srinivas SD; Puri SK
    Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):901-3. PubMed ID: 12386719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
    Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
    mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.